Hesse holds investment support prospects for Rhön-Klinikum | 01/14/22

Frankfurt (Dow Jones) – The State of Hesse promises investment subsidies to Rhön-Klinikum AG for the University Hospital Giessen and Marburg (UKGM) of up to €45 million annually for ten years. However, its payment is subject to a number of conditions. On Friday, the clinic’s board of directors announced the signing of a similar declaration of intent from the state of Hesse, the Rhön-Klinikum Hospital announced.

The promised investment subsidies, which will increase by 1.5 percent annually in the first five years of the term and by 2.5 percent annually in the second five years, can cover part of the necessary investments that will be made in the coming years. In order to preserve the clinical structures of the university. The continuation of the previous separate account is also scheduled. The declaration of intent also states, among other things, that the UKGM undertakes to retain its profits during this period, that regulations should be put in place if control changes, a moratorium on spin-offs and exclusion from the need for operational reasons.

All regulations are subject to the conclusion of a legally binding agreement between Rhön-Klinikum AG and Asklepios Kliniken GmbH & Co. In addition, the necessary funds have yet to be released by the Hesse budget legislature.

Contact the author: [email protected]

DJG / Sha / Rus

(end) Dow Jones Newswires

January 14, 2022 14:22 ET (19:22 GMT)